USA plans to share its entire stock of AstraZeneca vaccines

The USA plans to share its entire stock of vaccines from AstraZeneca once the COVID-19 vaccine clears federal safety reviews, the White House told Associated Press yesterday, as many as 60 million doses expected to be available for export in the coming months.